AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metaross 1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Bhumi Pharmaceuticals

Salt Composition

Metformin (1000mg)

Overview Metaross 1000mg Tablet SR

Diabex 1000mg Extended-Release tablets manage type 2 diabetes mellitus by regulating blood glucose, mitigating associated complications. This medication also treats Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize gastrointestinal distress, consume Diabex 1000mg ER with food, consistently at the same time daily. Discontinue use only under physician guidance. Maintaining a prescribed diet and exercise regimen is crucial for effective diabetes management. Common adverse reactions may encompass diarrhea, nausea, vomiting, gas, fatigue, dyspepsia, abdominal discomfort, cephalalgia, and anorexia. Concomitant use with other antidiabetic agents, alcohol, or missed meals may precipitate hypoglycemia; regular blood glucose monitoring is essential. Prior to initiating treatment, disclose any renal, hepatic, or cardiac conditions to your physician. Pregnant or lactating individuals should seek medical counsel before use. Baseline renal function assessment will precede treatment. Limit alcohol consumption to reduce the likelihood of adverse events.

Uses of Metaross 1000mg Tablet SR

Managing type 2 diabetes and polycystic ovary syndrome (PCOS)

Major Benefits of Metaross 1000mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. The Metaross 1000mg Tablet SR should be administered with a meal.

Common Side effects of Metaross 1000mg Tablet SR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Metaross 1000mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Metaross 1000mg Tablet SR should be administered with a meal.

How Metaross 1000mg Tablet SR works:

Glucovance 1000mg Extended-Release tablets are a biguanide-class antidiabetic agent. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Metaross 1000mg SR Tablet use poses a safety risk.

PregnancyPregnancySAFE IF PRESCRIBED

Extended-release Metaross 1000mg tablets are typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, clinical data from human trials are scarce.

Breast feedingBreast feedingCAUTION

Extended-release Metaross 1000mg tablets require careful consideration during lactation. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metaross 1000mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Metaross 1000mg SR tablets are contraindicated in individuals with severe kidney disease.

LiverLiverUNSAFE

Patients with liver disorders should likely refrain from using Metaross 1000mg SR tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Metaross 1000mg Tablet SR :

Should you forget a Metaross 1000mg Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Metaross 1000mg Tablet SR

LabelValue
Type of Compound Guanidine-based antidiabetic agent
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Metaross 1000mg Tablet SR

Individuals with type 2 diabetes exhibit impaired responsiveness to their own insulin. This results in elevated blood glucose concentrations. Metaross 1000mg Tablet SR employs a multifaceted approach to lower these high blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption post-prandially, and enhances insulin sensitivity in bodily tissues. This facilitates improved glucose uptake from the bloodstream. Consequently, it improves the body's natural insulin response.
Individuals overweight or obese taking Metaross 1000mg Tablet SR have demonstrated weight reduction. This medication may also modestly decrease weight in overweight or obese patients predisposed to diabetes. Furthermore, insulin-resistant or insulin-sensitive patients might experience weight loss. However, self-medicating with this drug for weight management is inadvisable; physician consultation is essential.
Metaross 1000mg Tablet SR is an initial treatment option for hyperglycemia. This medication manages blood glucose levels by enhancing the body's insulin response, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, Metaross 1000mg Tablet SR, when used monotherapy, infrequently leads to hypoglycemia due to its inhibition of excessive insulin secretion. Beyond glycemic control, this medication also aids in weight management.
Metaross 1000mg sustained-release tablets generally don't induce drowsiness and are well-received. Infrequently, though, Metaross 1000mg sustained-release tablets may lead to sleep disturbances and insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Seek medical advice if fatigue or sleepiness develops during Metaross 1000mg sustained-release tablet use.
Administer Metaross 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing the tablets; ingest them whole with water. For once-daily regimens, consume the tablet in the morning with breakfast. Twice-daily prescriptions should be divided, one with breakfast and one with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metaross 1000mg SR tablets with food mitigates potential gastrointestinal distress including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their body's own insulin. This results in elevated blood glucose concentrations. Metaross 1000mg Tablet SR employs a multi-pronged approach to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption following meals, and enhances insulin sensitivity in bodily tissues. This combined action facilitates improved glucose uptake from the bloodstream. Furthermore, it promotes a more effective response to naturally produced insulin.
Individuals overweight or obese have experienced weight reduction while using Metaross 1000mg SR tablets. This weight loss effect may also be observed in overweight or obese individuals pre-diabetic. Furthermore, insulin-resistant or insulin-sensitive patients may likewise exhibit weight loss. However, self-prescribing Metaross for weight management is strongly discouraged; physician consultation is essential.
Metaross 1000mg Extended-Release tablets are frequently an initial treatment for hyperglycemia. This medication manages blood glucose by enhancing the body's insulin response, reducing hepatic glucose production, and diminishing intestinal glucose absorption. Differing from other oral hypoglycemics, Metaross 1000mg Extended-Release tablets, when used monotherapy, infrequently induce hypoglycemia due to their inhibition of excessive insulin release. Beyond its glycemic control benefits, this medication also aids in weight management.
Metaross 1000mg sustained-release tablets generally do not induce drowsiness and are well-received. Nevertheless, infrequent instances of sleep disturbances and insomnia have been reported with Metaross 1000mg SR. Somnolence may indicate a severe adverse reaction known as lactic acidosis, especially in individuals with impaired renal function. Consult your physician if fatigue or sleepiness develops during Metaross 1000mg SR treatment.
Administer Metaross 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, take it with breakfast. Twice-daily prescriptions should be divided between morning and evening meals. Three times daily, distribute the doses with breakfast, lunch, and dinner. Consuming Metaross 1000mg sustained-release tablets with food mitigates potential gastrointestinal issues such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their body's naturally produced insulin. This results in elevated blood glucose levels. Metaross 1000mg Tablet SR employs a multifaceted approach to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes postprandial intestinal glucose absorption, and enhances insulin sensitivity in bodily tissues. This combined action facilitates improved glucose uptake from the bloodstream and optimizes the body's natural insulin response.
Metaross 1000mg SR tablets have demonstrated weight reduction in overweight and obese patients. This weight loss effect may also be observed in overweight and obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance might experience weight loss. However, self-initiation of Metaross for weight management is discouraged; physician consultation is essential.
Among the initial treatments prescribed for hyperglycemia is Metaross 1000mg Tablet SR. This medication facilitates blood glucose regulation by enhancing the body's insulin response, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, Metaross 1000mg Tablet SR, when used monotherapy, infrequently leads to hypoglycemia due to its inhibition of excessive insulin release. Beyond its efficacy in glycemic control, this medication also aids in managing weight increase.
Metaross 1000mg sustained-release tablets generally don't induce drowsiness and are well-received. Infrequently, though, Metaross 1000mg SR tablets can lead to sleep disturbances and insomnia. Drowsiness might signal a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Metaross 1000mg SR treatment.
Administer Metaross 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, morning administration with breakfast is recommended. Twice-daily regimens should involve morning and evening doses, taken with breakfast and dinner, respectively. Three times daily, take the medication with breakfast, lunch, and dinner. Consuming Metaross 1000mg sustained-release tablets with food mitigates potential gastrointestinal issues such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Metaross 1000mg Tablet SR
30
MRP 35
14% off